Adjuvant Therapy for Esophageal Squamous Cell Carcinoma
10.5090/kjtcs.2020.53.4.168
- Author:
Jong-Mu SUN
1
Author Information
1. Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- Publication Type:Collective of current Review, Lecture
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2020;53(4):168-171
- CountryRepublic of Korea
-
Abstract:
Adjuvant therapy for completely resected esophageal squamous cell carcinoma is lesscommonly applied in clinical practice than neoadjuvant therapy, but it plays a substantialrole in improving survival for esophageal cancer patients. This article presents a concise reviewof the evidence regarding adjuvant therapy for esophageal squamous cell carcinomaand future directions, particularly immunotherapy.
